Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SGEN - Agenus Vs. Seattle Genetics Cervical Cancer Clinical Trial Results

SGEN - Agenus Vs. Seattle Genetics Cervical Cancer Clinical Trial Results

Seagen Inc.
  • Agenus's balstilimab and zalifrelimab nears FDA submission for cervical cancer.
  • Seattle Genetics presented tisotumab vedotin cervical cancer data at ESMO.
  • They may compete in the marketplace despite differing mechanisms of action.

For further details see:

Agenus Vs. Seattle Genetics Cervical Cancer Clinical Trial Results
Stock Information
Company Name: Seagen Inc.
Stock Symbol: SGEN
Market: NASDAQ
Website: seagen.com
Menu
SGEN SGEN Quote SGEN Short SGEN News SGEN Articles SGEN Message Board
Get SGEN Alerts

News, Short Squeeze, Breakout and More Instantly...